NO163184C - Analogifremgangsm te for fremstilling av terapeutisk aktive 4h-3, 1-benzoksazin-4-on-derivater. - Google Patents
Analogifremgangsm te for fremstilling av terapeutisk aktive 4h-3, 1-benzoksazin-4-on-derivater.Info
- Publication number
- NO163184C NO163184C NO845176A NO845176A NO163184C NO 163184 C NO163184 C NO 163184C NO 845176 A NO845176 A NO 845176A NO 845176 A NO845176 A NO 845176A NO 163184 C NO163184 C NO 163184C
- Authority
- NO
- Norway
- Prior art keywords
- benzoksazin
- derivatives
- preparation
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C265/00—Derivatives of isocyanic acid
- C07C265/16—Derivatives of isocyanic acid having isocyanate groups acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
- C07C273/1809—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety
- C07C273/1818—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety from -N=C=O and XNR'R"
- C07C273/1827—X being H
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56612983A | 1983-12-27 | 1983-12-27 | |
US60860984A | 1984-05-09 | 1984-05-09 | |
US06/673,996 US4657893A (en) | 1984-05-09 | 1984-11-26 | 4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO845176L NO845176L (no) | 1985-06-28 |
NO163184C true NO163184C (no) | 1990-04-18 |
Family
ID=27415984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO845176A NO163184C (no) | 1983-12-27 | 1984-12-21 | Analogifremgangsm te for fremstilling av terapeutisk aktive 4h-3, 1-benzoksazin-4-on-derivater. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0147211B1 (fr) |
KR (1) | KR890000992B1 (fr) |
CA (1) | CA1269800A (fr) |
DE (1) | DE3483204D1 (fr) |
DK (1) | DK625184A (fr) |
ES (2) | ES8607260A1 (fr) |
FI (1) | FI79842C (fr) |
HU (1) | HU195648B (fr) |
IL (1) | IL73943A (fr) |
NO (1) | NO163184C (fr) |
NZ (1) | NZ210669A (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1309556C (fr) * | 1987-06-09 | 1992-10-27 | Masayuki Kokubo | Composes 4h-3,1-benzoxazin-4-one et leurs compositions pharmaceutiques utilisees pour l'inhibition de proteases de la serine |
AU645836B2 (en) * | 1990-09-10 | 1994-01-27 | Asahi Kasei Kogyo Kabushiki Kaisha | Benzoic acid phenylester compounds and elastase inhibiting compositions containing the same |
US5652237A (en) * | 1994-09-09 | 1997-07-29 | Warner-Lambert Company | 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes |
US5985872A (en) * | 1995-05-24 | 1999-11-16 | G.D. Searle & Co. | 2-amino-benzoxazinones for the treatment of viral infections |
GB9700597D0 (en) * | 1997-01-14 | 1997-03-05 | Sandoz Pharma Uk | Organic compounds |
WO1999048878A1 (fr) * | 1998-03-24 | 1999-09-30 | Novo Nordisk A/S | Composes heterocycliques regulateurs de coagulation |
US6180625B1 (en) | 1998-03-24 | 2001-01-30 | Novo Nordisk A/S | Heterocyclic compounds regulating clotting |
WO2000030646A1 (fr) * | 1998-11-26 | 2000-06-02 | Novo Nordisk A/S | Composes heterocycliques regulant la coagulation |
GB9900416D0 (en) * | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
HUP0201213A3 (en) | 1999-01-22 | 2003-02-28 | Wyeth Corp | Pirimidinyl, pirazinyl and thiadiazolyl phenylalanin derivatives which treat vla-4 related disorders and pharaceutical compositions containing them |
IL143928A0 (en) * | 1999-01-22 | 2002-04-21 | Elan Pharm Inc | Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
US6436904B1 (en) | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
WO2007041324A1 (fr) | 2005-09-29 | 2007-04-12 | Elan Pharmaceuticals, Inc. | Composes de pyrimidinyl amide qui inhibent l'adherence leucocytaire a mediation par vla-4 |
AU2006297220B8 (en) | 2005-09-29 | 2013-01-31 | Elan Pharmaceuticals, Inc. | Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
CA2643838A1 (fr) | 2006-02-27 | 2007-09-07 | Elan Pharmaceuticals, Inc. | Composes de sulfonamide de pyrimidinyle inhibant l'adhesion leucocytaire mediee par vla-4 |
BRPI1015259A2 (pt) | 2009-04-27 | 2016-05-03 | Elan Pharm Inc | antagonistas de piridinona de integrinas alfa-4 |
US20200109126A1 (en) * | 2017-01-06 | 2020-04-09 | The Regents Of The University Of California | Mu opioid receptor modulators |
JP7402857B2 (ja) | 2018-04-04 | 2023-12-21 | エピオダイン,インク. | オピオイド受容体モジュレーター、およびそれに関連する生成物ならびに方法 |
TW202304869A (zh) | 2021-04-05 | 2023-02-01 | 美商艾碧奧戴股份有限公司 | 類鴉片受體調節劑 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3450700A (en) * | 1966-12-20 | 1969-06-17 | Upjohn Co | 2-tertiary amino-4h-3,1-benzoxazin-4-ones |
DE2315303A1 (de) * | 1973-03-27 | 1974-10-17 | Bayer Ag | Verfahren zur herstellung von n-substituierten 2-amino-3,1-benzoxazin-4-onen |
-
1984
- 1984-12-20 NZ NZ210669A patent/NZ210669A/en unknown
- 1984-12-21 CA CA000470962A patent/CA1269800A/fr not_active Expired - Fee Related
- 1984-12-21 EP EP84309013A patent/EP0147211B1/fr not_active Expired - Lifetime
- 1984-12-21 DK DK625184A patent/DK625184A/da not_active Application Discontinuation
- 1984-12-21 NO NO845176A patent/NO163184C/no unknown
- 1984-12-21 DE DE8484309013T patent/DE3483204D1/de not_active Expired - Fee Related
- 1984-12-26 KR KR1019840008352A patent/KR890000992B1/ko not_active IP Right Cessation
- 1984-12-26 ES ES539038A patent/ES8607260A1/es not_active Expired
- 1984-12-26 IL IL73943A patent/IL73943A/xx unknown
- 1984-12-27 HU HU844839A patent/HU195648B/hu not_active IP Right Cessation
- 1984-12-27 FI FI845116A patent/FI79842C/fi not_active IP Right Cessation
-
1986
- 1986-01-14 ES ES550879A patent/ES8703437A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FI79842C (fi) | 1990-03-12 |
KR890000992B1 (ko) | 1989-04-15 |
HUT36808A (en) | 1985-10-28 |
KR850004472A (ko) | 1985-07-15 |
ES8703437A1 (es) | 1987-03-01 |
NZ210669A (en) | 1988-05-30 |
ES8607260A1 (es) | 1986-06-01 |
FI845116A0 (fi) | 1984-12-27 |
EP0147211A2 (fr) | 1985-07-03 |
DE3483204D1 (de) | 1990-10-18 |
IL73943A (en) | 1989-01-31 |
FI79842B (fi) | 1989-11-30 |
DK625184A (da) | 1985-06-28 |
EP0147211B1 (fr) | 1990-09-12 |
CA1269800A (fr) | 1990-05-29 |
EP0147211A3 (en) | 1985-08-14 |
FI845116L (fi) | 1985-06-28 |
DK625184D0 (da) | 1984-12-21 |
NO845176L (no) | 1985-06-28 |
IL73943A0 (en) | 1985-03-31 |
HU195648B (en) | 1988-06-28 |
ES550879A0 (es) | 1987-03-01 |
ES539038A0 (es) | 1986-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO163451C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminomethyloxooxazolidinylbenzenderivater. | |
NO166639C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner. | |
NO165838C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte trans-1,2-diamino-cykloheksylamidforbindelser. | |
NO162764C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater. | |
NO162022C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater. | |
NO159531C (no) | Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater. | |
NO165239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater. | |
NO156864B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater. | |
NO162514C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater. | |
NO165192C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater. | |
NO163184C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive 4h-3, 1-benzoksazin-4-on-derivater. | |
NO152129C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater | |
NO164097C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater. | |
NO156787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
NO161562C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater. | |
NO159654C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater. | |
NO161676C (no) | Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater. | |
NO164169C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzothiazinderivater. | |
NO159930C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater. | |
NO161559C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater. | |
NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
NO158941C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater. | |
NO160079C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater. | |
NO161738C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive imidazolinderivater. | |
NO155840C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive taurin-derivater. |